Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Pharmacodynamic Model-Based Safety Management of Eribulin-Induced Myelosuppression in Patients With Breast Cancer.
Ther Drug Monit. 2023 Jun 1;45(3):318-326. doi: 10.1097/FTD.0000000000001036.
Ther Drug Monit. 2023.
PMID: 36150714
Pharmacodynamic analysis of eribulin safety in breast cancer patients using real-world postmarketing surveillance data.
Kawamura T, Kasai H, Fermanelli V, Takahashi T, Sakata Y, Matsuoka T, Ishii M, Tanigawara Y.
Kawamura T, et al. Among authors: fermanelli v.
Cancer Sci. 2018 Sep;109(9):2822-2829. doi: 10.1111/cas.13708. Epub 2018 Jul 23.
Cancer Sci. 2018.
PMID: 29933506
Free PMC article.
Item in Clipboard
Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes.
Taskinen MR, Björnson E, Kahri J, Söderlund S, Matikainen N, Porthan K, Ainola M, Hakkarainen A, Lundbom N, Fermanelli V, Fuchs J, Thorsell A, Kronenberg F, Andersson L, Adiels M, Packard CJ, Borén J.
Taskinen MR, et al. Among authors: fermanelli v.
Arterioscler Thromb Vasc Biol. 2021 Feb;41(2):962-975. doi: 10.1161/ATVBAHA.120.315446. Epub 2020 Dec 24.
Arterioscler Thromb Vasc Biol. 2021.
PMID: 33356392
Free article.
Item in Clipboard
Cite
Cite